.Merck trumps earnings requirements, increases purchases outlook on powerful requirement for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Projections as Keytruda Purchases Surge BloombergMerck Stock: Pharma Giant Posts Powerful Outcomes, However Outlook Drops Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue as well as sales assumptions amidst Keytruda advantage, however supplies mixed full-year expectation MarketWatch.